• Achieving high star ratings is associated with increased likelihood of new beneficiary enrollment and enrollment from existing Medicare beneficiaries switching from lower-rated plans. CMS quality bonus payments also provide increased revenue opportunities for plans with high star ratings. 
T he late Mark H. Beers, MD, a geriatrician, is widely known for his contribution to geriatric care through the development of a list of potentially inappropriate medications (PIMs) used by the elderly. Published in 1991, the "Beers Criteria" of PIMs was developed to reduce inappropriate medication use in nursing home patients. 1 The 1997 update expanded the criteria for application to all ambulatory older persons. 2 The last update under Dr. Beer's auspices was published in 2003 and stood as the definitive criteria for nearly a decade. 3 The American Geriatric Society (AGS) sponsored the 2012 Beers Criteria update, which included many improvements, such as following the Institute of Medicine standard of evidence and transparency for creating guidelines. 4, 5 The use of the Beers Criteria expands beyond individual practitioners or institutions of care. The National Committee for Quality Assurance first included a performance measure based on the Beers Criteria known as "Use of HighRisk Medications in the Elderly," in the 2006 Healthcare Effectiveness Data and Information Set (HEDIS), a tool for health plans to measure care and service performance. 6 The High-Risk Medication (HRM) measure was subsequently adapted and endorsed by the Pharmacy Quality Alliance (PQA), endorsed by the National Quality Forum, and adopted by the Centers for Medicare & Medicaid Services (CMS). Consistent with HEDIS and PQA, CMS included the revised 2012 AGS Beers Criteria into the HRM measure specifications for the 2015 star ratings for measuring HRM use in the 2013 benefit year. CMS includes the HRM measure in the Part D star
• The Beers Criteria for potentially inappropriate medications to be used in the elderly and, more recently, the updated 2012 American Geriatric Society (AGS) Beers Criteria, have been adapted into the quality performance measure High-Risk Medications (HRM) used in Centers for Medicare & Medicaid (CMS) star ratings.
• CMS has placed an emphasis on the member experience with several star rating measures related to member satisfaction that have a greater total weight contribution to the overall summary star rating than the individual HRM star rating measure.
What is already known about this subject
• The results of this study indicate that the HRM star rating measure score and its improvement, prior to the implementation of the updated 2012 AGS Beers Criteria, have minimal influence on the member experience star ratings measure scores.
• This information may be used by plan sponsors in making informed decisions regarding HRM utilization management.
What this study adds
interventions, such as educational mailings intended to influence prescribing behavior, are not likely to have an immediate or dramatic effect. Requiring prior authorization approval for HRMs or formulary exclusion of HRMs are likely to cause significant member disruption, negatively impacting the member experience. HRMs are often older, generic medications that members have been able to obtain easily prior to turning 65 and enrolling in a Medicare plan. Safe, low-cost alternatives are not always available. Plans with poor HRM star ratings may be hesitant to implement management strategies with the assumption that this may have an unintended negative impact on member satisfaction scores, which have a greater total weight contribution to the overall summary star rating. The purpose of our analysis was to determine the relationship of the HRM score and the change in HRM score to relevant member experience measures.
■■ Methods Study Design
This is a cross-sectional analysis utilizing the 2 most recently released CMS star ratings reports (i.e., the 2013 and 2014 star ratings reports that use 2011 and 2012 benefit years, respectively). These reports can be found on the CMS website.
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Data
Each October, prior to open enrollment for the upcoming benefit year, the most recent star ratings results are available on the CMS website. The report is named for the coming benefit year.
ratings for Medicare Advantage prescription drug (MA-PD) plans and stand-alone prescription drug plans (PDPs). Star ratings summarize the performance of contracted health and drug plans on various indicators of clinical quality, care access, customer service, and member satisfaction. Contracts receive 1 to 5 stars, with 5 stars representing the highest quality for each individual performance measure, as well as for aggregate groupings of like measures referred to as domains and an overall summary rating.
Star ratings are important to contracting plans for several reasons. The Affordable Care Act of 2010 requires quality bonus payments and rebates to be tied to star ratings. 7 Also, low-performing contracts risk exclusion from Medicare, since past performance is a consideration in the approval of applications. 8 Lastly, CMS star ratings are posted publicly to help beneficiaries choose plans. An association has been recently established between Medicare Advantage plan star ratings and enrollment numbers. 9 Reid et al. (2013) found that new enrollees were more likely to enroll in plans with higher star ratings, and continuing enrollees were more likely to switch to plans with higher star ratings. 9 The HRM star ratings measure is 1 of 5 triple-weighted medication-related patient safety measures that comprise 19% of the Part C rating or 54% of the Part D rating. CMS has also placed an emphasis on the member experience with several star rating measures related to member satisfaction. Case-mix adjusted percentage of the best possible score the plan earned on how easy it is for members to get the prescription drugs they need using the plan CAHPS survey questions:
In the last 6 months, how often was it easy to use your health plan to get the medicines your doctor prescribed?
In the last 6 months, how often was it easy to use your health plan to fill a prescription at a local pharmacy?
In the last 6 months, how often was it easy to use your health plan to fill prescriptions by mail?
1.5
Members' rating of drug plan
Case-mix adjusted percentage of the best possible score the plan earned from members who rated the prescription drug plan CAHPS survey question:
Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan? The measures of interest for this analysis included the Patient Safety measure HRM and all measures that were determined to be potentially negatively impacted by formulary restrictions. Four measures within the domains of "Member Experience with the Drug Plan" and "Member Complaints, Problems Getting Services, and Improvement in the Drug Plan's Performance" were included as follows: Getting Needed Prescription Drugs; Members' Rating of Drug Plan; Complaints About the Drug Plan; and Members Choosing to Leave the Plan (Table 1) .
Inclusion Criteria
Medicare contracts with base-level detail and star ratings for all measures of interest in both the 2013 and the 2014 star ratings reports were included. Contracts with "No data available," "Not enough data available," "Plan too new to be measured," or "CMS identified issues with this plan's data" in place of base data or star ratings for the 5 measures of interest were excluded ( Figure 1 ).
High-Risk Medication Measure (Explanatory or Independent Variable)
The HRM performance measure for 2013 and 2014 star ratings (2011 and 2012 benefit year, respectively) is reported as the percentage of members aged 65 years and older enrolled during 
Medicare Contracts Included in 2013-2014 Star Ratings Reports and Included in Analysis
the benefit year with at least 2 fills for a prescription medication that has a high risk for adverse events in the elderly. The base score is calculated for members aged 65 years and older from prescription drug event claims data files provided by drug plans to CMS throughout the benefit year.
Patient Satisfaction Measures (Dependent Variables)
Getting Needed Prescription Drugs. Data for the Getting Needed Prescription Drugs performance measure are acquired through the CAHPS survey. Three questions from the CAHPS survey are used to calculate the Getting Needed Prescription Drugs base score:
• "In the last 6 months, how often was it easy to use your health plan to get the medicines your doctor prescribed?" • "In the last 6 months, how often was it easy to use your health plan to fill a prescription at a local pharmacy?" • "In the last 6 months, how often was it easy to use your health plan to fill prescriptions by mail?" The CAHPS survey is administered between February 15 through May 31 after the benefit year by CMS-approved vendors by mail and telephone to a random sampling of members. The measure is reported as the percentage of the best possible CAHPS survey score. It is a case-mix adjusted measure that takes into account socioeconomic differences (such as age, education level, and dual eligibility) of enrollees across contracts. Members Choosing to Leave the Plan. The Members Choosing to Leave the Plan performance measure is reported as the percentage of members who chose to disenroll from the plan during the benefit year. This is calculated by taking the number of members who chose to disenroll using disenrollment codes in Medicare's enrollment system, excluding members who disenrolled due to reasons beyond their control (e.g., relocation out of the service area, disenrollment due to low-income subsidy reassignments, or not meeting requirements for special needs plans), and dividing the number by the number of members enrolled at any time during the benefit year.
Statistical Analysis
Bivariate regressions were performed for 2 independent variables: (1) 2014 star ratings HRM base score (2012 benefit year) and (2) the change in HRM base score from the 2013 to 2014 star ratings reports (2011 and 2012 benefit years; Table 2 member experience measures of interest are collected in a time period following the benefit year. It is therefore possible that changes in the formulary management of HRMs could affect member experience measures of the previous benefit year's star ratings report for members enrolled in the same contract in both years. Regressions were performed for each independent variable and dependent variable pair within the same report year and within the same year of data collection.
Regression analyses were also performed on a subgroup of Medicare contracts that achieved a 2-star or greater increase in the HRM measure from 2013 star ratings (2011 benefit year) to 2014 star ratings (2012 benefit year). These contracts may represent those that made significant changes in the management of HRMs to achieve this improvement.
If achieving an excellent HRM base score (lower is better) was associated with a negative impact on member experience measures, positive associations would be observed for the 2 measures Getting Needed Prescription Drugs and Rating of Drug Plan (higher is better) and negative associations would be observed for the 2 measures Complaints About the Drug Plan and Members Choosing to Leave the Plan (lower is better).
Bivariate linear regression models were performed in Microsoft Excel 2010. A two-tailed P value < 0.05 was considered statistically significant. Table 3 ). As the data collection is measured after the benefit year for 3 of the 4 member experience measures, bivariate linear regressions were performed for the 2014 star ratings 
■■ Results
Bivariate Linear Regression for All Plans with Complete Information for 5 Measures in 2013 and 2014 (n = 443)
Rating of Drug Plan measure base scores, which explain 1% to 2% of the variance (R 2 ). Bivariate regressions were performed using the change in HRM base scores for a subgroup of Medicare contracts that achieved a 2-star or greater improvement in the HRM measure ( Table 4 ). The only significant association between the explanatory variable and member experience measures was for the 2014 Getting Needed Prescription Drugs measure (P = 0.02), which explains 7% (R 2 ) of the variance in the model.
■■ Discussion
The results of this analysis indicate that the HRM score and the HRM score change are marginally able to predict member experience star ratings measure scores. The HRM score and the HRM score change had the greatest influence on the Getting Needed Prescription Drugs measure (R 2 = 0.04 and R 2 = 0.08, respectively). However, the magnitude of this association is small. The corresponding correlation coefficients (R) of 0.21 and 0.29 suggest that there are likely limited linear associations between the variables. 11 Scatter plots of the data points (plots not shown) for each dependent and independent variable pair show single clusters with 1 to 4 outliers. Bivariate regressions were repeated after excluding outliers. The size of the variance and association did not change appreciably after removing the outliers (data not shown). The only change in the significance testing occurred for the result of the 2014 HRM and the 2014 Complaints about Drug Plan regression, which became nonsignificant after outlier removal.
The HRM score was generally more predictive of the concurrent member experience star ratings measures than previous year's member experience star ratings measures. Since the member experience data are often captured after the benefit year, the effect of HRM formulary restrictions may be diluted over multiple years. benefit year), the HRM star ratings measure has been updated based on the 2012 AGS Beers Criteria. There are many significant differences between the HRMs listed prior to the 2013 benefit compared with the present version. Many medications were deleted (e.g., cimetidine, diazepam, and phentermine), and several new medications have been added (e.g., glyburide, indomethacin, and guanfacine). Another significant change is the addition of medications with daily dosage or cumulative days' supply limits in addition to or in place of the 2 fills criterion. Nonbenzodiazepine hypnotics (i.e., esczopiclone, zolpidem, and zaleplon) are included as HRMs when the cumulative days' supply is greater than 90 days. Future analysis should be conducted to determine the relationship between HRM management strategies, HRM score, and member experience scores in the 2015 star ratings (2013 benefit year) and beyond.
Other limitations of this analysis include not being able to control for socioeconomic differences in patient populations across Medicare contracts. This study used publicly available Medicare contract performance results, which do not include demographic data. Also, we did not have access to reasons for disenrollment or to complaint type logged in the CTM, which may explicate the impact of formulary restrictions on these measures.
■■ Conclusions
The results of regression analyses suggest that the HRM star rating measure score and its improvement have minimal influence on the member experience star ratings measure scores. Plan sponsors may be more aggressive in the management of HRM utilization to increase patient safety and clinical quality without compromising member experience performance measures. Safety-related formulary restriction implementations intended to improve the HRM star rating score are unlikely to cause decreases in member satisfaction that would negatively impact summary star ratings. Furthermore, increasing the HRM star rating score is likely to improve summary star ratings. Further research is needed to determine the impact of different methods of HRM star rating improvement on member satisfaction using the current AGS Beers Criteria. models than the 2014 the HRM score. It is intuitive that an increase in HRM score, the more significant of which is likely the result of increased formulary restrictiveness, would be more likely to be associated with a marked impact to member experience measures. The models' beta-coefficients suggest that HRM score improvement negatively impacts all member satisfaction measures.
However, the results indicate an overall minimal contribution to the member experience measures. This is likely due to many factors influencing the overall member experience and the intentionally broad nature of the CAHPS survey questions. That is, there may be several reasons influencing member response to the CAHPS survey questions that may or may not be related to HRM usage. Members may give greater consideration to perceived cost burdens, consisting of pharmacy benefit premiums and prescription copayments, rather than to prescription medication access when rating their prescription drug plans or choosing to leave their plans. It is also possible that the timing of survey administration chosen by CMS results in significant recall bias. Additionally, only a small proportion of members surveyed are likely to have utilized or tried to fill an HRM. The mean prevalence of members meeting HRM criteria for the 2014 star ratings report across all contracts is 6%. 10 The degree of restrictiveness and the extent to which drug utilization is managed through prior authorization across the entire formulary may have considerable negative repercussions on the Getting Needed Prescription Drug star rating, compared with strict management of the HRM category alone. Plans with greater HRM dispensing rates may observe a more significant impact on patient satisfaction measures by restricting access to HRMs than plans with smaller HRM prevalence.
The subanalysis of Medicare contracts achieving a 2-star or greater increase in the HRM measure yielded 1 significant regression between the change in the HRM score and the 2014 Getting Needed Prescription Drugs that explained 7% of variance. Contracts with a 2-star or greater increase represent those who likely implemented formulary changes between the 2011 and 2012 benefit years to restrict the use of HRMs. It is likely that these improvements were accomplished through formulary restrictions, since educational outreach is generally associated with more gradual improvements. However, the specific utilization management techniques employed by these plans are unknown, and some interventions may have greater negative impact on the Getting Needed Prescription Drugs score than others. The subanalysis may also be limited by the small sample size (n = 81) and unmeasured differences from the entire cohort of contracts.
Limitations
The applicability of these results may be limited by the changes in the HRM list. Beginning with the 2015 star ratings (2013
